FUNGIZONE POWDER FOR SOLUTION
국가: 캐나다
언어: 영어
출처: Health Canada
제품 특성 요약
(SPC)
12-12-2019
이 제품에 대한 일부 문서는 현재 사용할 수 없습니다. 고객 서비스에 요청을 보내면 가능한 빨리 알려 드리겠습니다.
요청을 보내십시오.
요청을 보내십시오.
유효 성분:
AMPHOTERICIN B
제공처:
CHEPLAPHARM ARZNEIMITTEL GMBH
ATC 코드:
J02AA01
INN (International Name):
AMPHOTERICIN B
복용량:
50MG
약제 형태:
POWDER FOR SOLUTION
구성:
AMPHOTERICIN B 50MG
관리 경로:
INTRAVENOUS
패키지 단위:
15G/50G
처방전 유형:
Prescription
치료 영역:
POLYENES
제품 요약:
Active ingredient group (AIG) number: 0105864001; AHFS:
승인 상태:
APPROVED
승인 날짜:
2018-06-08
제품 특성 요약
MONOGRAPHIE DE PRODUIT
PR
FUNGIZONE
MD
AMPHOTÉRICINE B POUR INJECTION, NORME MANUFACTURER
POUR PERFUSION INTRAVEINEUSE
50 MG/FIOLE
ANTIFONGIQUE
12 décembre 2019
Date de la révision :
N
o
de contrôle : 233219
Tel: 1-888-XEDITON
Ontario L5N 1W1
2000 Argentia Rd, Mississauga,
Xediton Pharmaceuticals Inc,
Distribué par
GmbH
MD
de La Société CHEPLAPHARM Arzneimittel
Ziegelhof 24, 17489 Greifswald, Germany
CHEPLAPHARM Arzneimittel GmbH
CLASSIFICATION THÉRAPEUTIQUE
......................................................................................
3
ACTIONS ET PHARMACOLOGIE
CLINIQUE............................................................................
3
INDICATIONS ET USAGE CLINIQUE
.......................................................................................
3
CONTRE-INDICATION
..............................................................................................................
5
MISES EN GARDE
....................................................................................................................
5
PRÉCAUTIONS
.........................................................................................................................
5
RÉACTIONS INDÉSIRABLES
...................................................................................................
7
SYMPTÔMES ET TRAITEMENT DU SURDOSAGE
................................................................. 9
POSOLOGIE ET ADMINISTRATION
.........................................................................................
9
RENSEIGNEMENTS PHARMACEUTIQUES
............................................................................13
PRÉSENTATION DES FORMES POSOLOGIQUES
................................................................14
MICROBIOLOGIE
.....................................................................................................................14
PHARMACOLOGIE
..................................................................................................................16
TOXICOLOGIE
.........
전체 문서 읽기
